In vivo measurement of ethanol metabolism in the rat liver using magnetic resonance spectroscopy of hyperpolarized [1-13C]pyruvate

Magnetic Resonance in Medicine

Volumn 62, Issue 2, 2009, Pages 307-313

  Spielman, Daniel M ^a   Mayer, Dirk ^a,b   Yen, Yi Fen ^c   Tropp, James ^c   Hurd, Ralph E ^c   Pfefferbaum, Adolf ^b,d  

^a STANFORD UNIVERSITY   (United States)

^b SRI INTERNATIONAL   (United States)

^c GE HEALTHCARE   (United States)

^d STANFORD UNIVERSITY   (United States)

Author keywords

Ethanol metabolism; Magnetic resonance spectroscopy

Indexed keywords

COENZYMES; DISEASES; ETHANOL; MAGNETIC RESONANCE; MAGNETIC RESONANCE SPECTROSCOPY; MAGNETISM; RATS;

ANAEROBIC METABOLISM; ETHANOL CONSUMPTION; FATTY LIVER DISEASE; IN-VIVO MEASUREMENT; LACTATE CONVERSION; MAGNETIC RESONANCE SPECTROSCOPIES (MRS); NICOTINAMIDE ADENINE DINUCLEOTIDES; NON-INVASIVELY MONITORING;

METABOLISM;

ALCOHOL; CARBON 13; LACTIC ACID; NICOTINAMIDE ADENINE DINUCLEOTIDE; PYRUVIC ACID; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE;

AEROBIC METABOLISM; ALCOHOL CONSUMPTION; ALCOHOL METABOLISM; ANAEROBIC METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; DRUG METABOLISM; FATTY LIVER; HYPERPOLARIZATION; LIVER CIRRHOSIS; LIVER DISEASE; LIVER METABOLISM; MALE; NEOPLASM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RAT;

ANIMALS; CARBON ISOTOPES; ETHANOL; LIVER; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PYRUVIC ACID; RADIOPHARMACEUTICALS; RATS; RATS, WISTAR;

EID: 67749099703     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.21998     Document Type: Article

References (34)

1. Berg J, Tymoczko J, Stryer L. Biochemistry. New York: W.H. Freeman; 2006.
2. Ong JP, Younossi ZM. Epidemiology and natural history of NAFLD and NASH. Clin Liver Dis 2007;11:1-16, vii.
3. Randi G, Altieri A, Gallus S, Franceschi S, Negri E, Talamini R, La Vecchia C. History of cirrhosis and risk of digestive tract neoplasms. Ann Oncol 2005;16:1551-1555.
4. Voigt MD. Alcohol in hepatocellular cancer. Clin Liver Dis 2005;9:151-169.
5. Forsander OA, Maenpaa PH, Salaspuro MP. Influence of ethanol on the lactate/pyruvate and beta-hydroxybutiate/acetoacetate ratios in rat liver experiments. Acta Chem Scand 1965;19:1770-1771.
6. Jue T, Arias-Mendoza F, Gonnella NC, Shulman GI, Shulman RG. A 1H NMR technique for observing metabolite signals in the spectrum of perfused liver. Proc Natl Acad Sci U S A 1985;82:5246-5249.
7. de Graaf R. In vivo NMR spectroscopy. Chichester, UK: John Wiley & Sons; 1998.
8. Abragam A. The principles of nuclear magnetism. London: Oxford University Press; 1961.
9. Ardenkjaer-Larsen JH, Fridlund B, Gram A, Hansson G, Hansson L, Lerche MH, Servin R, Thaning M, Golman K. Increase in signal-to-noise ratio of > 10,000 times in liquid-state NMR. Proc Natl Acad Sci U S A 2003;100:10158-10163.
10. Golman K, Ardenkjaer-Larsen JH, Petersson JS, Mansson S, Leunbach I. Molecular imaging with endogenous substances. Proc Natl Acad Sci U S A 2003;100:10435-10439.
11. Golman K, Zandt RI, Lerche M, Pehrson R, Ardenkjaer-Larsen JH. Metabolic imaging by hyperpolarized 13C magnetic resonance imaging for in vivo tumor diagnosis. Cancer Res 2006;66:10855-10860.
12. Day SE, Kettunen MI, Gallagher FA, Hu DE, Lerche M, Wolber J, Golman K, Ardenkjaer-Larsen JH, Brindle KM. Detecting tumor response to treatment using hyperpolarized 13C magnetic resonance imaging and spectroscopy. Nat Med 2007;13:1382-1387.
13. Olsson LE, Chai CM, Axelsson O, Karlsson M, Golman K, Petersson JS. MR coronary angiography in pigs with intraarterial injections of a hyperpolarized 13C substance. Magn Reson Med 2006;55:731-737.
14. Golman K, Olsson LE, Axelsson O, Mansson S, Karlsson M, Petersson JS. Molecular imaging using hyperpolarized 13C. Br J Radiol 2003;76(Spec No 2):S118-127.
15. Mansson S, Johansson E, Magnusson P, Chai CM, Hansson G, Petersson JS, Stahlberg F, Golman K. 13C imaging - a new diagnostic platform. Eur Radiol 2006;16:57-67.
16. Golman K, Petersson JS. Metabolic imaging and other applications of hyperpolarized 13C1. Acad Radiol 2006;13:932-942.
17. Kohler SJ, Yen Y, Wolber J, Chen AP, Albers MJ, Bok R, Zhang V, Tropp J, Nelson S, Vigneron DB, Kurhanewicz J, Hurd RE. In vivo 13 carbon metabolic imaging at 3T with hyperpolarized 13C-1-pyruvate. Magn Reson Med 2007;58:65-69.
18. Derby K, Tropp J, Hawryszko C. Design and evaluation of a novel dual-tuned resonator for spectroscopic imaging. J Magn Reson 1990;88:645-665.
19. Ljung L. Systems identification: theory for the user. Upper Saddle River, NJ: Prentice-Hall PRT; 1999.
20. Woods HF, Krebs HA. Lactate production in the perfused rat liver. Biochem J 1971;125:129-139.
21. Tussey L, Felder MR. Tissue-specific genetic variation in the level of mouse alcohol dehydrogenase is controlled transcriptionally in kidney and posttranscriptionally in liver. Proc Natl Acad Sci U S A 1989;86:5903-5907.
22. Cunningham CH, Chen AP, Lustig M, Lupo J, Xu D, Kurhanewicz J, Hurd RE, Pauly JM, Nelson SJ, Vigneron DB. Pulse sequence for dynamic volumetric imaging of hyperpolarized metabolic products. J Magn Reson 2008;193:139-146.
23. Mayer D, Levin YS, Hurd RE, Glover GH, Spielman DM. Fast metabolic imaging of systems with sparse spectra: application for hyperpolarized 13C imaging. Magn Reson Med 2006;56:932-937.
24. Begriche K, Igoudjil A, Pessayre D, Fromenty B. Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. Mitochondrion 2006;6:1-28.
25. Wei Y, Rector RS, Thyfault JP, Ibdah JA. Nonalcoholic fatty liver disease and mitochondrial dysfunction. World J Gastroenterol 2008;14:193-199.
26. Lam JP, Mays DC, Lipsky JJ. Inhibition of recombinant human mitochondrial and cytosolic aldehyde dehydrogenases by two candidates for the active metabolites of disulfiram. Biochemistry 1997;36:13748-13754.
27. Mays DC, Tomlinson AJ, Johnson KL, Lam J, Lipsky JJ, Naylor S. Inhibition of human mitochondrial aldehyde dehydrogenase by metabolites of disulfiram and structural characterization of the enzyme adduct by HPLC-tandem mass spectrometry. Adv Exp Med Biol 1999;463:61-70.
28. Quintanilla ME, Tampier L. Brain mitochondrial aldehyde dehydrogenase: relation to acetaldehyde aversion in low-alcohol-drinking (UChA) and high-alcohol-drinking (UChB) rats. Addict Biol 2003;8:387-397.
29. Poli G, Schaur RJ, Siems WG, Leonarduzzi G. 4-Hydroxynonenal: a membrane lipid oxidation product of medicinal interest. Med Res Rev 2008;28:569-631.
30. Aberle NS 2nd, Burd L, Zhao BH, Ren J. Acetaldehyde-induced cardiac contractile dysfunction may be alleviated by vitamin B1 but not by vitamins B6 or B12. Alcohol 2004;39:450-454.
31. Vetterlein F, Schrader C, Volkmann R, Neckel M, Ochs M, Schmidt G, Hellige G. Extent of damage in ischemic, nonreperfused, and reperfused myocardium of anesthetized rats. Am J Physiol Heart Circ Physiol 2003;285:H755-765.
32. Szocs K, Lassegue B, Wenzel P, Wendt M, Daiber A, Oelze M, Meinertz T, Munzel T, Baldus S. Increased superoxide production in nitrate tolerance is associated with NAD(P)H oxidase and aldehyde dehydrogenase 2 downregulation. J Mol Cell Cardiol 2007;42:1111-1118.
33. Jones DE Jr, Evces S, Lindahl R. Expression of tumor-associated aldehyde dehydrogenase during rat hepatocarcinogenesis using the resistant hepatocyte model. Carcinogenesis 1984;5:1679-1687.
34. Ohsawa I, Nishimaki K, Yasuda C, Kamino K, Ohta S. Deficiency in a mitochondrial aldehyde dehydrogenase increases vulnerability to oxidative stress in PC12 cells. J Neurochem 2003;84:1110-1117.